Evaluation of predictive factors of toxicity of chemotherapy with FOLFIRINOX in patients treated for pancreatic adenocarcinoma

被引：0
|
作者：
Eid, R. [1 ]
Tarabay, A. [2 ]
Decazes, P. [2 ]
David, C. [1 ]
Kerbage, F. [1 ]
Zeghondy, J. [1 ]
Antoun, L. [1 ]
Smolenschi, C. [2 ]
Fuerea, A. [1 ]
Valery, M. [1 ]
Boige, V. [1 ]
Gelli, M. [1 ]
Tselikas, L. [1 ]
Labrunie, J. Durand [1 ]
Belkouchi, Y. [1 ]
Ducreux, M. [1 ]
Lassau, N. [1 ]
Hollebecque, A. [2 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Gustave Roussy, Dept Med Oncol, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.187
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-131
引用
收藏
页码：S61 / S62
页数：2
相关论文
共 50 条
  • [21] Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
    Lee, So Heun
    Hwang, Dae Wook
    Yoo, Changhoon
    Kim, Kyu-pyo
    Kang, Sora
    Jeong, Jae Ho
    Oh, Dongwook
    Song, Tae Jun
    Lee, Sang Soo
    Park, Do Hyun
    Seo, Dong Wan
    Park, Jin-hong
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Park, Yejong
    Kwak, Bong Jun
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Kim, Song Cheol
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 956 - 968
  • [22] Markers of tumour inflammation are prognostic for overall survival in patients with advanced pancreatic ductal adenocarcinoma receiving FOLFIRINOX chemotherapy
    Appleyard, J.
    Kamposioras, K.
    Papaxoinis, G.
    Collinson, F.
    Ahmad, U.
    Wright, F.
    Damyanova, I.
    Razzaq, M.
    Anthoney, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S131 - S131
  • [23] Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy
    Ueno, H
    Okada, S
    Okusaka, T
    Ikeda, M
    ONCOLOGY, 2000, 59 (04) : 296 - 301
  • [24] Important Radiologic and Clinical Factors for Predicting Overall Survival in Pancreatic Adenocarcinoma Patients Who Underwent FOLFIRINOX
    Park, Sae-Jin
    Kim, Jung Hoon
    Choi, Seo-Youn
    Joo, Ijin
    PANCREAS, 2024, 53 (07) : e553 - e559
  • [25] Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer
    Haderlein, M.
    Lubgan, D.
    Lettmaier, S.
    Semrau, S.
    Wolf, W.
    Golcher, H.
    Hohenberger, W.
    Fietkau, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 15 - 15
  • [26] Circulating microRNA-181a monitors response to FOLFIRINOX chemotherapy in pancreatic ductal adenocarcinoma
    Meijer, Laura L.
    Garajova, Ingrid
    Caparello, Chiara
    Le Large, Tessa Y. S.
    Funel, Niccola
    Vasile, Enrico
    Kazemier, Geert
    Giovannetti, Elisa
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Survival and Predictive Factors of Chemotherapy With FOLFIRINOX as First-Line Therapy in Metastatic Pancreatic Cancer A Retrospective Multicentric Analysis
    Caron, Benedicte
    Reimund, Jean-Marie
    Ben Abdelghani, Meher
    Sondag, Daniel
    Noirclerc, Monique
    Duclos, Bernard
    Kurtz, Jean-Emmanuel
    Nguimpi-Tambou, Marlene
    PANCREAS, 2021, 50 (06) : 803 - 806
  • [28] FOLFIRINOX in patients with peritonea carcinomatosis from pancreatic adenocarcinoma: a retrospective study
    Bonnet, E.
    Mastier, C.
    Lardy-Cleaud, A.
    Rochefort, P.
    Sarabi, M.
    Guibert, P.
    Cattey-Javouhey, A.
    Desseigne, F.
    de la Fouchardiere, C.
    CURRENT ONCOLOGY, 2019, 26 (04) : E466 - E472
  • [29] Folfirinage: Tolerance and efficacy of folfirinox in elderly patients with advanced pancreatic adenocarcinoma
    Baldini, C.
    Escande, A.
    Bouche, O.
    Bourgeois, V.
    Renaut-Vantroys, T.
    Ploquin, A.
    Desauw, C.
    Hebbar, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S196 - S196
  • [30] Efficacy and safety of FOLFIRINOX in elderly patients with advanced pancreatic adenocarcinoma.
    Jung, Jae Hyup
    Kang, Jingu
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345